Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 206 (RNA5SP206) is a processed pseudogene derived from the gene encoding 5S ribosomal RNA. 5S ribosomal RNA is a highly conserved non-coding RNA that is a structural component of the large ribosomal subunit, playing a central role in ribosome assembly and function in protein synthesis[1][5]. However, as a pseudogene, RNA5SP206 does not produce a functional RNA product and lacks the capacity to encode or act as a ribosomal RNA. Pseudogenes like RNA5SP206 originate from gene duplication or retrotransposition events, and typically accumulate mutations that disable their original function[2][4]. While some pseudogenes have been implicated in gene regulation or disease as competing endogenous RNAs or sources of small RNAs, there is currently no evidence that RNA5SP206 exhibits any known biological or disease-associated function[2][6]. It is not a therapeutic target nor associated with known biomarker or drug interactions. Key notes: - 5S ribosomal RNA is a structural RNA essential to ribosome integrity, but this pseudogene does not serve that role[3][5]. - Pseudogenes are categorized based on their origin (processed, unprocessed, or unitary), with RNA5SP206 likely being a processed pseudogene due to its derivation from retrotransposed RNA[2]. - Most pseudogenes are not druggable targets and are not considered in the context of classic pharmacological modulation[2][6]. - There are no notable safety, efficacy, or biomarker implications for this pseudogene in current scientific or medical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 206 (RNA5SP206).